Literature DB >> 24790646

Sphenopalatine ganglion stimulation for the treatment of cluster headache.

Miguel J A Láinez1, Miguel Puche2, Ana Garcia3, Francisco Gascón3.   

Abstract

Cluster headache is a severe, debilitating disorder with pain that ranks among the most severe known to humans. Patients with cluster headaches have few therapeutic options and further, 10-20% develop drug-resistant attacks. The often brief duration of cluster attacks makes abortive therapy a challenge, and preventive medications are almost always provided to patients, but the side effects of these preventive medications can be significant. The sphenopalatine ganglion (SPG) is believed to play a role in headache pain and cranial autonomic symptoms associated with cluster headache, which is a result of activation of the trigeminal-autonomic reflex. For over 100 years, the SPG has been a clinical target to treat primary headache disorders using pharmacologic and nonpharmacologic methods. Radiofrequency lesioning and nerve-resection therapies, while initially beneficial, are irreversible procedures, and the use of neurostimulation provides one method of interfacing with the neural pathways without causing permanent damage to neural tissue. SPG neurostimulation is both reversible and adjustable, and has recently been tested in both proof-of-concept work and in a randomized, sham-controlled trial for the treatment of cluster headache. A randomized, sham-controlled study of 32 patients was performed to evaluate further the use of SPG stimulation for the acute treatment of chronic cluster headache. Of the 32 patients, 28 completed the randomized experimental period. Overall, 68% of patients experienced an acute response, a frequency response, or both. In this study the majority of adverse events were related to the implantation procedure, which typically resolved or remained mild in nature at 3 months following the implant procedure. This and other studies highlight the promise of using SPG stimulation to treat the pain-associated cluster headache. SPG stimulation could be a safe and effective option for chronic cluster headache.

Entities:  

Keywords:  cluster headache; neurostimulation; sphenopalatine ganglion

Year:  2014        PMID: 24790646      PMCID: PMC3994920          DOI: 10.1177/1756285613510961

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  47 in total

1.  Treatment of acute cluster headache with sumatriptan.

Authors: 
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  Sphenopalatine ganglion pulsed radiofrequency treatment in 30 patients suffering from chronic face and head pain.

Authors:  Erin Bayer; Gabor B Racz; Day Miles; James Heavner
Journal:  Pain Pract       Date:  2005-09       Impact factor: 3.183

Review 3.  Cluster headache: pathogenesis, diagnosis, and management.

Authors:  Arne May
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

4.  Cryosurgery of headache.

Authors:  N Cook
Journal:  Res Clin Stud Headache       Date:  1978

5.  Cyberknife targeting the pterygopalatine ganglion for the treatment of chronic cluster headaches.

Authors:  Shivanand P Lad; John D Lipani; Iris C Gibbs; Steven D Chang; John R Adler; Jaimie M Henderson
Journal:  Neurosurgery       Date:  2007-03       Impact factor: 4.654

Review 6.  The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation.

Authors:  A May; P J Goadsby
Journal:  J Cereb Blood Flow Metab       Date:  1999-02       Impact factor: 6.200

7.  Sphenopalatine ganglion radiofrequency ablation for the management of chronic cluster headache.

Authors:  Samer Narouze; Leonardo Kapural; Jose Casanova; Nagy Mekhail
Journal:  Headache       Date:  2008-09-09       Impact factor: 5.887

Review 8.  Cluster headache, hypothalamus, and orexin.

Authors:  Philip R Holland; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2009-04

9.  Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation.

Authors:  Stewart J Tepper; Ali Rezai; Samer Narouze; Charles Steiner; Pouya Mohajer; Mehdi Ansarinia
Journal:  Headache       Date:  2009-05-26       Impact factor: 5.887

10.  Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain.

Authors:  S Markowitz; K Saito; M A Moskowitz
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

View more
  5 in total

1.  Radiological anatomy assessment of the fissura pterygomaxillaris for a surgical approach to ganglion pterygopalatinum.

Authors:  Miguel Puche-Torres; Arantxa Blasco-Serra; Ana Campos-Peláez; Alfonso A Valverde-Navarro
Journal:  J Anat       Date:  2017-09-28       Impact factor: 2.610

2.  Peripheral Nerve Stimulation in Pain Management: A Systematic Review.

Authors:  Jijun Xu; Zhuo Sun; Jiang Wu; Maunak Rana; Joshua Garza; Alyssa C Zhu; Krishnan V Chakravarthy; Alaa Abd-Elsayed; Ellen Rosenquist; Hersimren Basi; Paul Christo; Jianguo Cheng
Journal:  Pain Physician       Date:  2021-03       Impact factor: 4.965

3.  Transnasal sphenopalatine ganglion block for the treatment of postdural puncture headache following spinal anesthesia.

Authors:  Shivakumar M Channabasappa; Shonali Manjunath; Basavaraj Bommalingappa; Sreenivas Ramachandra; S Banuprakash
Journal:  Saudi J Anaesth       Date:  2017 Jul-Sep

4.  Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache.

Authors:  Mohamed Binfalah; Eman Alghawi; Eslam Shosha; Ali Alhilly; Moiz Bakhiet
Journal:  Pain Res Treat       Date:  2018-05-07

Review 5.  Facial nerve stimulation as a future treatment for ischemic stroke.

Authors:  Mark K Borsody; Emilio Sacristan
Journal:  Brain Circ       Date:  2016-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.